| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1053954138 |
| P356 | DOI | 10.1186/S13014-016-0750-3 |
| P932 | PMC publication ID | 5251326 |
| P698 | PubMed publication ID | 28107823 |
| P50 | author | Carsten Herskind | Q42703099 |
| P2093 | author name string | Lin Ma | |
| Bo Zhang | |||
| Frank Schneider | |||
| Qi Liu | |||
| Frederik Wenz | |||
| Marlon R Veldwijk | |||
| P2860 | cites work | Evidence for formation of DNA repair centers and dose-response nonlinearity in human cells | Q24609012 |
| Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses | Q24677973 | ||
| Multicentricity of breast cancer: whole-organ analysis and clinical implications | Q24679799 | ||
| Accelerated Partial Breast Irradiation in Clinical Practice | Q26776283 | ||
| The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved? | Q26823489 | ||
| Intraoperative Electron Radiotherapy (IOERT) as an Alternative to Standard Whole Breast Irradiation: Only for Low-Risk Subgroups? | Q26864258 | ||
| Treatment of Breast and Prostate Cancer by Hypofractionated Radiotherapy: Potential Risks and Benefits | Q26998991 | ||
| Factors determining DNA double-strand break repair pathway choice in G2 phase | Q28118755 | ||
| Late radiation toxicity after intraoperative radiotherapy (IORT) for breast cancer: results from the randomized phase III trial TARGIT A. | Q49109112 | ||
| Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. | Q49165929 | ||
| Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial. | Q50754518 | ||
| No significant endothelial apoptosis in the radiation-induced gastrointestinal syndrome. | Q51021200 | ||
| Radiation-induced lung damage after thoracic irradiation for Hodgkin's disease: the role of fractionation. | Q51047696 | ||
| Survival and tumour control probability in tumours with heterogeneous oxygenation: a comparison between the linear-quadratic and the universal survival curve models for high doses. | Q51074850 | ||
| Soft X-ray dosimetry and RBE for survival of Chinese hamster V79 cells. | Q51608357 | ||
| Imaging features that discriminate between foci induced by high- and low-LET radiation in human fibroblasts. | Q51630517 | ||
| Cellular response to pulsed low-dose rate irradiation in X-ray sensitive hamster mutant cell lines. | Q51820892 | ||
| Expression of phosphorylated histone H2AX in cultured cell lines following exposure to X-rays. | Q51834143 | ||
| A new incomplete-repair model based on a 'reciprocal-time' pattern of sublethal damage repair. | Q52132284 | ||
| The linear-quadratic model and most other common radiobiological models result in similar predictions of time-dose relationships. | Q52240518 | ||
| Repair kinetics in pig epidermis: an analysis based on two separate rates of repair. | Q52320154 | ||
| An integrated logistic formula for prediction of complications from radiosurgery. | Q52519196 | ||
| Recovery kinetics deduced from continuous low dose-rate experiments. | Q52535838 | ||
| An 'incomplete-repair' model for survival after fractionated and continuous irradiations. | Q52675324 | ||
| Inter-individual variation in DNA double-strand break repair in human fibroblasts before and after exposure to low doses of ionizing radiation. | Q53304915 | ||
| Dosimetric characterization of INTRABEAM® miniature accelerator flat and surface applicators for dermatologic applications. | Q53311760 | ||
| Toward a unified survival curve: in regard to Park et al. (IntJ Radiat Oncol Biol Phys 2008;70:847-852) and Krueger et al. (Int J Radiat Oncol Biol Phys 2007;69:1262-1271). | Q53538861 | ||
| Accelerated partial breast irradiation with intraoperative electrons: using GEC-ESTRO recommendations as guidance for patient selection. | Q53756743 | ||
| Local Recurrences and Distant Metastases After Conservative Breast Cancer Treatments: Partly Independent Events | Q54145502 | ||
| No apoptotic endothelial cells in irradiated intestine: regarding Schuller et al. (Int J Radiat Oncol Biol Phys 2007;68:205-210). | Q54587550 | ||
| Preclinical studies with the photon radiosurgery system (PRS). | Q55475597 | ||
| Engaging the vascular component of the tumor response | Q57359877 | ||
| Relationship between early and late normal-tissue injury after postmastectomy radiotherapy | Q57618722 | ||
| The Linear-Quadratic Model Is Inappropriate to Model High Dose per Fraction Effects in Radiosurgery | Q57730424 | ||
| Complications from arteriovenous malformation radiosurgery: Multivariate analysis and risk modeling | Q61832821 | ||
| Split Dose Recovery Studies using Homologous Recombination Deficient Gene Knockout Chicken B Lymphocyte Cells | Q63965559 | ||
| DNA repair in the context of chromatin: new molecular insights by the nanoscale detection of DNA repair complexes using transmission electron microscopy | Q64386909 | ||
| Induction of DNA strand breaks, base lesions and clustered damage sites in hydrated plasmid DNA films by ultrasoft X rays around the phosphorus K edge | Q64387311 | ||
| Lethal and potentially lethal lesions induced by radiation--a unified repair model | Q64390425 | ||
| Radiobiology of ultrasoft X rays. I. Cultured hamster cells (V79) | Q69039629 | ||
| Induction of chromosome aberrations in human lymphocytes by monochromatic X-rays of quantum energy between 4.8 and 14.6 keV | Q69376922 | ||
| RBE of 20 kV and 70 kV X-rays determined for survival of V 79 cells | Q69674838 | ||
| Repair capacity and kinetics of human skin during fractionated radiotherapy: erythema, desquamation, and telangiectasia after 3 and 5 year's follow-up | Q69685712 | ||
| Saturable repair models of radiation action in mammalian cells | Q69853231 | ||
| Recovery from radiation damage in mouse lung: interpretation in terms of two rates of repair | Q70572133 | ||
| Tumor response to radiotherapy regulated by endothelial cell apoptosis | Q73401346 | ||
| Predicting realistic RBE values for clinically relevant radiotherapy schedules | Q73562848 | ||
| Ectopic expression of a COOH-terminal fragment of the human telomerase reverse transcriptase leads to telomere dysfunction and reduction of growth and tumorigenicity in HeLa cells | Q74198983 | ||
| Electron spectra and the RBE of X rays | Q74318140 | ||
| Clinical relative biological effectiveness of low-energy x-rays emitted by miniature x-ray devices | Q74592446 | ||
| The role of cytokines in the development of normal-tissue reactions after radiotherapy | Q77606033 | ||
| Early mammographic and sonographic findings after intraoperative radiotherapy (IORT) as a boost in patients with breast cancer | Q79610923 | ||
| Extending the linear-quadratic model for large fraction doses pertinent to stereotactic radiotherapy | Q81063080 | ||
| Radiobiological aspects of intraoperative radiotherapy (IORT) with isotropic low-energy X rays for early-stage breast cancer | Q81294143 | ||
| Sphere of equivalence--a novel target volume concept for intraoperative radiotherapy using low-energy X rays | Q82700981 | ||
| A dosimetric comparison of IORT techniques in limited-stage breast cancer | Q83351847 | ||
| A novel device for intravaginal electronic brachytherapy | Q84104826 | ||
| Radiobiological comparison of hypofractionated accelerated partial-breast irradiation (APBI) and single-dose intraoperative radiotherapy (IORT) with 50-kV X-rays | Q84965684 | ||
| Breast-conserving surgery and intraoperative electron radiotherapy in early breast cancer: experience at the Rambam Health Care Campus | Q85279221 | ||
| Are mammographic changes in the tumor bed more pronounced after intraoperative radiotherapy for breast cancer? Subgroup analysis from a randomized trial (TARGIT-A) | Q85507909 | ||
| Do we need "biology-based" models to describe cell survival curves after exposure to ionizing radiation? | Q86581480 | ||
| IOERT as anticipated tumor bed boost during breast-conserving surgery after neoadjuvant chemotherapy in locally advanced breast cancer--results of a case series after 5-year follow-up | Q88218008 | ||
| Targeted intraoperative radiotherapy impairs the stimulation of breast cancer cell proliferation and invasion caused by surgical wounding | Q28271265 | ||
| Pathways of DNA double-strand break repair during the mammalian cell cycle | Q28608969 | ||
| A novel approach for superficial intraoperative radiotherapy (IORT) using a 50 kV X-ray source: a technical and case report. | Q30733408 | ||
| 12 Gy gamma knife radiosurgical volume is a predictor for radiation necrosis in non-AVM intracranial tumors | Q33225216 | ||
| Early initiation of external beam radiotherapy (EBRT) may increase the risk of long-term toxicity in patients undergoing intraoperative radiotherapy (IORT) as a boost for breast cancer | Q33354322 | ||
| Single-Center Long-Term Follow-Up After Intraoperative Radiotherapy as a Boost During Breast-Conserving Surgery Using Low-Kilovoltage X-Rays | Q33696000 | ||
| Requirement for Parp-1 and DNA ligases 1 or 3 but not of Xrcc1 in chromosomal translocation formation by backup end joining | Q33698679 | ||
| Quantitative clinical radiobiology of early and late lung reactions | Q33921090 | ||
| Long-term results of targeted intraoperative radiotherapy (Targit) boost during breast-conserving surgery | Q34144051 | ||
| Significance of endothelial dysfunction in the pathogenesis of early and delayed radiation enteropathy. | Q34232527 | ||
| Beyond repair foci: DNA double-strand break repair in euchromatic and heterochromatic compartments analyzed by transmission electron microscopy | Q34292873 | ||
| Intraoperative radiation therapy: a critical analysis of the ELIOT and TARGIT trials. Part 1--ELIOT. | Q34303451 | ||
| Intraoperative radiation therapy: a critical analysis of the ELIOT and TARGIT trials. Part 2--TARGIT | Q34303459 | ||
| A Monte Carlo based source model for dose calculation of endovaginal TARGIT brachytherapy with INTRABEAM and a cylindrical applicator. | Q34319186 | ||
| Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial | Q34384718 | ||
| In vivo optical imaging of tumor and microvascular response to ionizing radiation | Q34395430 | ||
| Selective irradiation of the vascular endothelium has no effect on the survival of murine intestinal crypt stem cells | Q34410739 | ||
| Relative Biologic Effectiveness (RBE) of 50 kV X-rays measured in a phantom for intraoperative tumor-bed irradiation | Q34415285 | ||
| Cathepsin L activity controls adipogenesis and glucose tolerance | Q34654358 | ||
| Formation of NHEJ-derived reciprocal chromosomal translocations does not require Ku70. | Q34728634 | ||
| ATM release at resected double-strand breaks provides heterochromatin reconstitution to facilitate homologous recombination | Q34917270 | ||
| Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review | Q35057465 | ||
| INTRAGO: intraoperative radiotherapy in glioblastoma multiforme—a phase I/II dose escalation study | Q35189570 | ||
| Radiation and ceramide-induced apoptosis | Q35208833 | ||
| Regulation of ceramide synthase-mediated crypt epithelium apoptosis by DNA damage repair enzymes | Q35633868 | ||
| Mechanisms of DNA double strand break repair and chromosome aberration formation | Q35783199 | ||
| The kinetics of repair for sublethal radiation-induced damage in the pig epidermis: an interpretation based on a fast and a slow component of repair | Q35907304 | ||
| Anti-ceramide antibody prevents the radiation gastrointestinal syndrome in mice | Q35913691 | ||
| Glycosphingolipids and cell death: one aim, many ways | Q36405917 | ||
| Radiation dose-volume effects in the brain. | Q36560171 | ||
| Ku-dependent non-homologous end-joining as the major pathway contributes to sublethal damage repair in mammalian cells | Q36565430 | ||
| Compatibility of the repairable-conditionally repairable, multi-target and linear-quadratic models in converting hypofractionated radiation doses to single doses | Q36661372 | ||
| The shape of the radiation dose response for DNA double-strand break induction and repair. | Q36741205 | ||
| Cell kinetics. | Q36776433 | ||
| Clinical aspects of intraoperative radiotherapy in early breast cancer: short-term complications after IORT in women treated with low energy x-rays. | Q36814821 | ||
| The relationship between waiting time for radiotherapy and clinical outcomes: a systematic review of the literature | Q37045313 | ||
| Gamma-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin | Q37261069 | ||
| The biological effect of large single doses: a possible role for non-targeted effects in cell inactivation | Q37504688 | ||
| Spatiotemporal characterization of ionizing radiation induced DNA damage foci and their relation to chromatin organization | Q37634166 | ||
| Dose-rate effects in external beam radiotherapy redux | Q37723716 | ||
| RBE of low energy electrons and photons | Q37739092 | ||
| The role of homologous recombination in radiation-induced double-strand break repair | Q37898827 | ||
| Radiation-induced vascular damage in tumors: implications of vascular damage in ablative hypofractionated radiotherapy (SBRT and SRS). | Q37974257 | ||
| Cancer stem cells as a predictive factor in radiotherapy | Q37990114 | ||
| Research opportunities in intraoperative radiation therapy: the next decade 2013-2023. | Q38086807 | ||
| DNA double-strand break repair as determinant of cellular radiosensitivity to killing and target in radiation therapy | Q38106985 | ||
| Present status and future directions of intraoperative radiotherapy | Q38147542 | ||
| Intraoperative radiation therapy techniques and options for breast cancer | Q38193576 | ||
| DNA double-strand break repair in a cellular context | Q38196085 | ||
| ATM regulates target switching to escalating doses of radiation in the intestines | Q38327055 | ||
| The Nuclear Factor κB pathway: A link to the immune system in the radiation response | Q38358248 | ||
| The radiobiology of hypofractionation. | Q38386825 | ||
| Alternative end-joining repair pathways are the ultimate backup for abrogated classical non-homologous end-joining and homologous recombination repair: Implications for the formation of chromosome translocations. | Q38621168 | ||
| Prolongation of overall treatment time as a cause of treatment failure in early breast cancer: An analysis of the UK START (Standardisation of Breast Radiotherapy) trials of radiotherapy fractionation. | Q39352887 | ||
| Characteristic 8 keV X rays possess radiobiological properties of higher-LET radiation. | Q39732778 | ||
| gammaH2AX foci analysis for monitoring DNA double-strand break repair: strengths, limitations and optimization | Q39742371 | ||
| Fitting techniques of cell survival curves in high-dose region for use in stereotactic body radiation therapy | Q39881919 | ||
| In vitro determination of radiation sensitivity parameters for DU-145 prostate cancer cells | Q39983637 | ||
| Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy | Q40014973 | ||
| Measurement of prompt DNA double-strand breaks in mammalian cells without including heat-labile sites: results for cells deficient in nonhomologous end joining | Q40663153 | ||
| Weiss Lecture. Effects of radiations of different qualities on cells: molecular mechanisms of damage and repair | Q40710240 | ||
| Cell inactivation and double-strand breaks: the role of core ionizations, as probed by ultrasoft X rays. | Q40752057 | ||
| Efficient rejoining of radiation-induced DNA double-strand breaks in vertebrate cells deficient in genes of the RAD52 epistasis group. | Q40799711 | ||
| Requirement for repair of DNA double-strand breaks by homologous recombination in split-dose recovery | Q40812740 | ||
| The relative biological effectiveness of 60Co gamma-rays, 55 kVp X-rays, 250 kVp X-rays, and 11 MeV electrons at low doses | Q41638236 | ||
| Alternative end-joining is suppressed by the canonical NHEJ component Xrcc4-ligase IV during chromosomal translocation formation | Q41874223 | ||
| The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction | Q41879769 | ||
| Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial | Q43427825 | ||
| IORT with electrons as boost strategy during breast conserving therapy in limited stage breast cancer: long term results of an ISIORT pooled analysis | Q43470885 | ||
| A generalized linear-quadratic model incorporating reciprocal time pattern of radiation damage repair | Q43733947 | ||
| Impact of the boost dose of 10 Gy versus 26 Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trial | Q44401637 | ||
| The addition of a boost dose on the primary tumour bed after lumpectomy in breast conserving treatment for breast cancer. A summary of the results of EORTC 22881-10882 "boost versus no boost" trial | Q44653649 | ||
| The 5Rs of radiobiology | Q44952713 | ||
| The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. | Q46425805 | ||
| A generalized linear-quadratic model for radiosurgery, stereotactic body radiation therapy, and high-dose rate brachytherapy | Q46540508 | ||
| Normal tissue complication probability (NTCP) parameters for breast fibrosis: pooled results from two randomised trials. | Q46858839 | ||
| Radiobiological analysis of tissue responses following radiosurgery | Q47984270 | ||
| Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery | Q48448781 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neoplasm | Q1216998 |
| intraoperative radiation therapy | Q3928881 | ||
| dose fractionation | Q5299253 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 24 | |
| P577 | publication date | 2017-01-19 | |
| P1433 | published in | Radiation Oncology | Q2313370 |
| P1476 | title | Biology of high single doses of IORT: RBE, 5 R's, and other biological aspects | |
| P478 | volume | 12 |
| Q92862781 | Enhancing the Bystander and Abscopal Effects to Improve Radiotherapy Outcomes |
| Q87944374 | Immune modulatory effects of radiotherapy as basis for well-reasoned radioimmunotherapies |
| Q38632924 | Immunotherapy Combined with Large Fractions of Radiotherapy: Stereotactic Radiosurgery for Brain Metastases-Implications for Intraoperative Radiotherapy after Resection |
| Q57110198 | Intraoperative Electron Radiotherapy (IOERT) in the Treatment of Primary Breast Cancer |
| Q39453639 | Intraoperative Radiation Therapy: A Promising Treatment Modality in Head and Neck Cancer |
| Q89586369 | Intraoperative radiotherapy for breast cancer treatment efficiently targets the tumor bed preventing breast adipose stromal cell outgrowth |
| Q38648229 | Keynote Address at the American Society of Breast Surgeons 18th Annual Meeting : Current and Future Application of Intraoperative Radiotherapy (IORT) in the Curative and Palliative Treatment of Breast Cancer |
| Q90066381 | Outcomes of immediate oncoplastic surgery and adjuvant radiotherapy in breast cancer patients |
| Q58587457 | Radiation Therapy Reduced Blood Levels of LDH, HIF-1α, and miR-210 in OSCC |
| Q92306377 | Radioimmunotherapy for the treatment of head and neck cancer |
| Q90376845 | Radiotherapy, tumor mutational burden, and immune checkpoint inhibitors: time to do the math |
Search more.